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Port-site tumour recurrence of oral squamous carcinoma following 
percutaneous endoscopic gastrostomy: a lesson to be aware of
Ian R Daniels*
Address: Pelican Cancer Foundation, North Hampshire Hospital, Aldermaston Road Basingstoke Hampshire RG24 9NA, UK
Email: Ian R Daniels* - i.daniels@pelicancancer.org
* Corresponding author    
Abstract
Background: Patients with aero-digestive malignancy will often require a feeding gastrostomy
during their treatment to maintain their nutritional status. These are usually placed percutaneously
using an endoscopic technique.
Case presentation: A fifty-six year old male underwent placement of a percutaneous
gastrostomy (PEG) prior to commencement of his treatment for an oral squamous cell carcinoma.
The treatment for this was locally curative. However, he developed a metastasis at the site of his
PEG tube. This was excised en-bloc with the anterior gastric and abdominal walls.
Conclusion: Tumour implantation into wounds has been previously reported. In this case the
direct trauma of passing the PEG tube through the oropharynx led to implantation of cells in the
anterior abdominal wall. In these cases laparoscopic placement may be more beneficial to avoid this
problem.
Background
Percutaneous endoscopic gastrostomy (PEG) is com-
monly used in patients with malignancy of the head and
neck to allow enteral nutrition to continue during the
peri-operative period. We report a case of a patient who
underwent PEG placement prior to surgery and adjuvant
radiotherapy for a squamous carcinoma of the tongue. Six
months post-resection the patient re-presented with a
recurrent tumour at the PEG site.
Case-presentation
The patient, a fifty-six year old man, presented with a
squamous cell carcinoma of the floor of the mouth with
metastases to the cervical nodes. He underwent PEG inser-
tion prior to radical neck dissection with a pectoralis
major flap reconstruction. Following surgery he under-
went a six-week course of adjuvant radiotherapy. The
patient represented three-months later with an iron-defi-
ciency anaemia and granulation tissue around the PEG
site. He was fully investigated with ultrasound scanning,
endoscopy, and computerized tomography. No cause for
his anaemia was found. Three months later he again pre-
sented with iron-deficiency anaemia and the area around
the PEG site had grown in size (Figure 1). This was biop-
sied and proved to be a squamous carcinoma. He was
then referred to this unit for consideration for surgery. He
was not initially keen on surgery and after discussion
underwent a trial of chemotherapy which after eight
weeks had made no difference to the size of the tumour.
He then accepted the need for surgery. At operation the
tumour mass, anterior abdominal wall and anterior gas-
tric wall were excised en-bloc with the PEG tube. A feeding
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Histology showed squamous carcinoma identical to the
original tumour with complete excision.
Discussion
Patients with malignancy of the head and neck are often
malnourished secondary to odynophagia or oropharyn-
geal obstruction. Because of the nature of the surgery,
swallowing may be impaired post-operatively and the
patient's nutritional status worsens. As the remainder of
the gastrointestinal tract remains functional, enteral feed-
ing is the favoured route of nutritional support. Nasogas-
tric feeding is contraindicated because of gastrointestinal
reflux, aspiration, nasal ulceration and frequent tube
blockage [1].
Percutaneous endoscopic gastrostomy (PEG) tubes have
replaced nasogastric tubes and Stamm gastrostomy tubes
as a means of feeding patients with head and neck carci-
noma. PEG tubes are usually placed using the 'pull-tech-
nique,' or 'push technique' The pull technique, the first
described method of PEG tube placement by Gauderer
and Ponsky, is widely used [2]. In both of these tech-
niques the tube is pulled or pushed through the orophar-
ynx into position in the stomach by an endoscopically
placed guide-wire which runs from the mouth to the
stomach and through the anterior abdominal wall [3].
Since the introduction of this technique there have been
at least fifteen case reports of tumour seeding at the gas-
trostomy site [4]. An alternative technique is the intro-
ducer technique (of Russell), which involves direct
placement through the abdominal wall [5].
Surgical implantation of tumour cells is a well-recognized
phenomenon that has been frequently reported in the lit-
erature. As early as 1885, Gertser put forward the view that
implantation of wounds by malignant cells could be the
cause of local recurrence. Lack in 1896 and Ryall in 1907
thought that 'infection' by malignant cells could occur
and suggested that contaminated surgical equipment was
responsible for implanting malignant cells in the opera-
tive field.
Conclusion
Patients with head and neck carcinoma usually have gas-
trostomy tubes placed prior to surgery but where the feed-
ing tube is passed over the oropharynx, tumour cells may
be carried on the tube and directly implanted into the
abdominal wall. In view of the fact that this is now at least
the sixteenth report of port-site recurrence it may be more
appropriate to insert a feeding gastrostomy tube laparo-
scopically at the time of the head and neck surgery. This
simple minimally invasive technique overcomes the risk
of implantation of cancer cells during insertion of a con-
ventional PEG. I would recommend this technique for
insertion of a feeding gastrostomy tube in patients with
head and neck cancer.
Conflict of interest




As neither the patient nor the next of kin could be contacted, permission 
was obtained from the Institute review board for publication of this case 
report.
References
1. Thorburn D, Karim SN, Souter DS, Mills PR: Tumour seeding fol-
lowing percutaneous endoscopic gastrostomy placement in
head and neck cancer.  Postgrad Med J 1997, 73:430-432.
2. Gauderer ML, Ponsky JL, Izant RJ: Gastrostomy without laparot-
omy: a percutaneous endoscopic technique.  J Paediatr Surg
1980, 15:872-875.
3. Schneider AM, Loggie BW: Metastatic head and neck cancer to
the percutaneous endoscopic gastrostomy exit site: a case
report and review of the literature.  Am Surg 1997, 63:481-486.
4. Alagaratnam TT, Ong GB: Wound implantation – a surgical haz-
ard.  Br J Surg 1977, 64:872-875.
5. Russell TR, Brotman M, Norris F: Percutaneous gastrostomy. A
new simplified and cost-effective technique.  Am J Surg 1984,
148:132-137.
The patient's PEG site at presentationFigure 1
The patient's PEG site at presentationPage 2 of 2
(page number not for citation purposes)
